Home
About NMSG
NMSG Membership
NMSG Fellowship
NMSG Shark Tank
NMSG Meetings
- 2026 Annual Neuromuscular Study Group Scientific Meeting
- Meetings Archive
Resources
- Publications
- Clinical Trials

Skip to content

Neuromuscular Study Group

Home
About NMSG
NMSG Membership
NMSG Fellowship
NMSG Shark Tank
NMSG Meetings
- 2026 Annual Neuromuscular Study Group Scientific Meeting
- Meetings Archive
Resources
- Publications
- Clinical Trials

Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis

Posted on April 7, 2016 by msg-admin

This study is active but not currently enrolling participants.

This entry was posted in MSG Studies, Terminated and tagged . Bookmark the permalink.

Post navigation

← Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis (Rasagiline)

Consortium for Clinical Investigation of Neurologic Channelopathies (CINCH) →

Search for:

Contact Us

Elizabeth Russo Paulk

Donna Schwartze

Site Search

Search for:

Sign up for our newsletter

Email (required) *

Select list(s) to subscribe to

General Interest

Example: Yes, I would like to receive emails from Neuromuscular Study Group. (You can unsubscribe anytime)

Constant Contact Use. Please leave this field blank.

By submitting this form, you are consenting to receive marketing emails from the Neuromuscular Study Group. You can revoke your consent at any time by using the SafeUnsubscribe® link found at the bottom of every email. Emails are serviced by Constant Contact.

© The Neuromuscular Study Group Inc. All rights reserved. Site by Academic Web Pages